CARTaGENE
CARTaGENE is a long-term cohort study for the investigation of modifiable environmental and lifestyle factors and the genomic determinants of chronic diseases in Quebec, Canada.
Overview
- Acronym
- CaG
- Website
- CaG
- Investigators
-
- Contacts
-
General Design
- Study design
- Cohort
- Start - End Year
- 2007 -
- General Information on Follow Up (profile, frequency)
-
After two recruitment phases, A in 2009 and B in 2012, preceded by a pilot phase (2008), a first follow-up was realized in 2017. Further follow-ups are planned regularly.
- Recruitment Target
-
- Individuals
- Number of Participants
- 43,046
- Number of Participants with Biological Samples
- 29,792
Access
Availability of data and biosamples
Possible Access to Data | |
Possible Access to Biosamples | |
Other |
|
Genetic data (Genotyping, RNA-seq, Whole Exome-seq, …)
Marker Papers
Awadalla P, Boileau C, Payette Y, Idaghdour Y, Goulet JP, Knoppers B, Hamet P, Laberge C, on behalf of the CARTaGENE Project, Cohort profile of the CARTaGENE study: Quebec's population-based biobank for public health and personalized genomics. Int J Epidemiol, 2013; 42:1285-1299.
PUBMED 23071140Timeline
Population
CaG population
The CaG cohort consists of men and women aged between 40 and 69 years residing in metropolitan areas of Quebec.
Selection Criteria
- Minimum age
-
40
- Maximum age
-
69
- Countries
-
- Canada
- Canadian Provinces
-
- Quebec
- Territory
- Montreal, Quebec, Sherbrooke and Saguenay for Phase A. Trois-Rivières and Gatineau added in Phase B.
- Other Criteria
- Participants were excluded if they were not registered in the FIPA files, if they resided outside the selected regions, lived in First Nations Reserves or long-term health care facilities or were in prison.
Sources of Recruitment
- General Population
-
- Selected sample
- Supplementary Information
-
Participants were randomly chosen to be broadly representative of the population based on provincial health insurance registries—FIPA files (fichier administratif des inscriptions des personnes assurées de la Régie de l’assurance maladie du Québec (RAMQ)).
Sample Size
- Number of Participants
- 43,046
- Number of Participants with Biological Samples
- 29,792
- Supplementary information about number of participants
-
Phase A: 20,004 participants
Phase B: 23,000 participants
Genealogical records’ number: 8,820
Data Collection Events
# | Name | Data sources | Data sources - Biosamples | Start | End |
---|---|---|---|---|---|
0 | CaG - Phase O |
|
|
2008 (February) | 2008 (February) |
1 | CaG - Phase A |
|
|
2009 (July) | 2010 (October) |
2 | CaG - Recontact Phase |
|
2011 (September) | 2012 (August) | |
3 | CaG - Phase B |
|
|
2012 (December) | 2015 (February) |
4 | CaG - Phase C |
|
2017 | 2018 | |
5 | CaG - COVID-19 Questionnaire |
|
2020 (July) | 2020 (October) |
Participating Studies
Acronym | Name | Study design | Countries |
---|
Harmonization Initiatives Included
Acronym | Name |
---|
Datasets
Name | Data Collection Events | Variables |
---|
Areas of Information Collected
- Socio-demographic and economic characteristics
- Death
- Lifestyle and behaviours
- Physical measures and assessments
- Birth, pregnancy and reproductive health history
- Laboratory measures
- Perception of health, quality of life, development and functional limitations
- Cognition, personality and psychological measures and assessments
- Diseases
- Life events, life plans, beliefs and values
- Symptoms and signs
- Preschool, school and work life
- Medication and supplements
- Social environment and relationships
- Non-pharmacological interventions
- Physical environment
- Health and community care services utilization
- Administrative information
Variables Content Summary
Areas of Information Collected
No Areas of Information Collected
No Scales Collected
Areas of Information Collected per per Population and Data Collection Event
No Areas of Information Collected
No Scales Collected
Networks
Acronym | Name | Harmonization Initiatives | Individual Studies |
---|
Last Update: 2024-11-27T16:26:00.497